Last reviewed · How we verify
Primaquine Diphosphate
At a glance
| Generic name | Primaquine Diphosphate |
|---|---|
| Also known as | Primaquine |
| Sponsor | London School of Hygiene and Tropical Medicine |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar (PHASE3)
- Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru
- Postpartum 8-aminoquinoline Breast Milk Study (PHASE2, PHASE3)
- An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria (PHASE3)
- Primaquine for Vivax Malaria in G6PD Intermediate and Deficient Cases. (PHASE4)
- Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana (NA)
- Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) (PHASE4)
- Short Course Primaquine for the Radical Cure of P. Vivax Malaria - Indonesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |